Wednesday 14 October 2026 Export MOH’s income statement to Excel — free account

Molina Healthcare, Inc

Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

209.87 5.51 +2.70%

Follow MOH

Alert me

Market cap: $10.7B
P/E: 0.0×
Fwd P/E: 55.0×
Dividend yield: —
F-score: 4/9
Altman Z: 4.28
Beneish M: −1.99
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.10

Total sells 3.56

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	1	—	—	—	—	—	—	—	—
Sell	1	—	—	—	1	—	2	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 10,670.00

Revenue 44,522.00

Net Income (7.00)

Free Cash Flow 271.00

Net Debt (4,962.00)

Current Ratio 1.68

Debt/Equity 0.95

P/E ratio 0.00

Fwd P/E 55.00

P/S ratio 0.24

P/B ratio 2.57

Past 5Y EPS Growth (4.50%)

This Y EPS Growth (52.49%)

Next Y EPS Growth 85.53%

Next Y revenue growth (2.14%)

Next 5Y EPS Growth 7.01%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 30.89%

10-year low 10-year high

P/B against its own 10 years 26.83%

10-year low 10-year high

EV/Sales against its own 10 years 31.15%

10-year low 10-year high

EV/FCF against its own 10 years 86.14%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	9,107	8,987	8,256	8,915
Receivables	3,104	3,299	3,533	3,485
Inventory	—	—	—	—
Other	—	—	—	—
	12,542	12,773	12,444	12,928

	2023	2024	2025	Q'26
Payables	1,252	1,331	1,093	1,139
ST’ Debt	—	—	—	—
Other	2,294	1,874	1,326	1,651
	8,168	7,896	7,372	7,700

Compound Annual Growth %

	10y	5y	3y
Sales	12.35%	18.52%	12.42%
Cash Flow	0.00%	0.00%	0.00%
Earnings	12.68%	(6.85%)	(15.85%)
Book Value	10.08%	14.19%	11.14%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	10,796	10,874	—	—	—
’25	11,147	11,427	11,477	11,375	45,426
’24	9,931	9,880	10,340	10,499	40,650
’23	8,149	8,327	8,548	9,048	34,072
’22	7,770	8,054	7,927	8,223	31,974
’21	6,522	6,800	7,040	7,409	27,771
’20	4,549	4,618	5,021	5,235	19,423

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1,082	(294)	—	—	—
’25	190	(302)	(125)	(298)	(535)
’24	214	(219)	873	(224)	644
’23	916	487	949	(690)	1,662
’22	363	368	254	(212)	773
’21	568	493	461	597	2,119
’20	143	614	(158)	1,299	1,898

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1,055	(324)	—	—	—
’25	168	(344)	(163)	(297)	(636)
’24	187	(246)	838	(235)	544
’23	884	456	923	(685)	1,578
’22	340	341	223	(222)	682
’21	552	480	434	576	2,042
’20	122	590	(177)	1,289	1,824

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.27	1.19	—	—	—
’25	5.45	4.75	1.51	(3.15)	8.92
’24	5.17	5.17	5.65	4.44	20.42
’23	5.52	5.35	4.21	3.70	18.77
’22	4.39	4.25	3.95	0.96	13.55
’21	3.89	3.16	2.46	1.74	11.25
’20	2.92	4.65	3.10	0.56	11.23

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	44.50	42.56	71.07	105.28	102.85	199.81	249.78	256.19	272.69	133.40	Analyst estimates 2026–2028 Powerpack
	High	67.87	80.74	154.06	159.00	224.00	328.11	374.00	384.72	423.92	359.97
People
People	Employees	21,000	20,000	11,000	10,000	10,500	14,000	15,000	123,123	18,000	19,000
	Revenue/emp, $m	0.85	0.99	1.72	1.68	1.85	1.98	2.13	0.28	2.26	2.39
Income, $m
Income, $m	Revenue	17,782	19,883	18,890	16,829	19,423	27,771	31,974	34,072	40,650	45,426
	Gross margin, %	14.19	11.66	17.94	17.37	18.55	14.64	15.01	15.86	15.31	13.07
	EBT	205	(612)	999	972	961	875	1,063	1,464	1,589	589
	EBT margin, %	1.15	(3.08)	5.29	5.78	4.95	3.15	3.32	4.30	3.91	1.30
	Net income	52	(512)	707	737	673	659	792	1,091	1,179	472
	Depreciation	182	210	127	89	88	131	176	171	186	195
Per share, $
Per share, $	Revenue	320.97	355.05	309.67	270.56	329.20	480.47	553.18	590.50	708.19	860.34
	Earnings	0.94	(9.07)	10.61	11.47	11.23	11.25	13.55	18.78	20.42	8.92
	Cash flow	12.15	14.36	(5.15)	6.98	32.17	36.66	13.37	28.80	11.22	(10.13)
	Capex	(3.18)	(1.54)	(0.49)	(0.92)	(1.25)	(1.33)	(1.57)	(1.46)	(1.74)	(1.91)
	Free cash flow	8.97	12.82	(5.64)	6.06	30.92	35.33	11.80	27.35	9.48	(12.05)
	Book value	29.77	23.88	27.00	31.51	35.53	45.50	51.28	73.05	78.33	77.06
	Shares, m	55	56	61	62	59	58	58	58	57	53
Valuation, ×
Valuation, ×	P/E	58.10	0.00	11.00	11.83	18.94	28.27	23.54	19.78	14.25	20.27
	P/S	0.17	0.22	0.38	0.50	0.65	0.66	0.58	0.63	0.41	0.20
	P/B	1.80	3.27	4.30	4.31	5.99	6.99	6.22	5.09	3.72	2.25
	EV/Sales	0.00	0.03	0.21	0.33	0.46	0.47	0.42	0.43	0.27	0.11
	EV/FCF	0.07	0.92	(11.75)	14.66	4.88	6.45	19.57	9.34	19.97	(7.68)
Cash, $m
Cash, $m	Operating cash flow	673	804	(314)	434	1,898	2,119	773	1,662	644	(535)
	Capex	(176)	(86)	(30)	(57)	(74)	(77)	(91)	(84)	(100)	(101)
	Free cash flow	497	718	(344)	377	1,824	2,042	682	1,578	544	(636)
Balance, $m
Balance, $m	Working capital	1,418	1,954	2,216	2,698	2,911	3,017	3,229	4,374	4,877	5,072
	Total debt	1,645	2,169	1,458	1,468	2,352	2,392	2,391	2,385	3,118	3,950
	Net debt	(2,932)	(3,710)	(3,049)	(2,930)	(3,677)	(5,248)	(5,114)	(6,722)	(5,869)	(4,306)
	Shareholders’ equity	1,649	1,337	1,647	1,960	2,096	2,630	2,964	4,215	4,496	4,069
Returns, %
Returns, %	ROA	0.74	(6.43)	9.05	10.57	8.25	6.06	6.46	8.02	7.73	3.03
	ROIC	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	ROE	3.24	(34.29)	47.39	40.86	33.19	27.89	28.32	30.39	27.07	11.02

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ELV Elevance Health, Inc.	$91.5B	18.8×	20.3×	+1.40% (above 0%: growing)	−13.08% (below 0%: shrinking)	−9.01% (below 0%: shrinking)	15.77%	4.56%	Compare
CI Cigna Group	$74.9B	11.7×	11.4×	+6.68% (above 0%: growing)	+10.16% (above 0%: growing)	+66.93% (above 0%: growing)	88.24%	3.73%	Compare
HUM Humana Inc.	$52.1B	39.5×	42.9×	+26.18% (above 0%: growing)	+27.88% (above 0%: growing)	+58.51% (above 0%: growing)	13.45%	3.33%	Compare
CNC Centene Corporation	$33.1B	— (loss-making)	24.8×	+9.92% (above 0%: growing)	n/m	+116.61% (above 0%: growing)	8.59%	2.24%	Compare
MOH Molina Healthcare, Inc	$10.7B	— (loss-making)	55.0×	−4.84% (below 0%: shrinking)	−74.95% (below 0%: shrinking)	+5.81% (above 0%: growing)	13.19%	1.33%
OSCR Oscar Health, Inc.	$10.5B	19.8×	29.7×	+70.40% (above 0%: growing)	n/m	+316.29% (above 0%: growing)	22.25%	7.96%	Compare
CLOV Clover Health Investments, Corp.	$2.5B	— (loss-making)	292×	+55.60% (above 0%: growing)	n/m	+406.43% (above 0%: growing)	20.59%	3.77%	Compare
PGNY Progyny, Inc.	$2.2B	28.2×	19.9×	+5.30% (above 0%: growing)	+80.00% (above 0%: growing)	−12.01% (below 0%: shrinking)	25.48%	11.41%	Compare
ALHC Alignment Healthcare, Inc.	$1.7B	39.5×	80.3×	+31.55% (above 0%: growing)	+125.00% (above 0%: growing)	−229.51% (below 0%: shrinking)	13.55%	3.15%	Compare
Median of peers	$21.8B	24.0×	27.3×	+18.05%	+27.88%	+62.72%	18.18%	3.75%

All 12 Healthcare Plans stocks →

Molina Healthcare, Inc (MOH) key facts

Strength: Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
Molina Healthcare, Inc (MOH) is a Healthcare Plans company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 13, 2026, MOH traded at $209.87, a market capitalization of $10.7 billion.
Return on equity was 11.0% and debt-to-equity 0.95.
Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 4.28 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.